Genetic and epigenetic regulation of human breast cancer progression and metastasis

¹ The Jake Gittlen Cancer Research Institute, Penn State University College of Medicine, Pennsylvania, USA
² Department of Physiology and Biophysics, Lombardi Cancer Center, 3970 Reservoir Road NW, Georgetown University Medical Center, Washington DC 20007, USA

Breast cancer is the most common malignancy and a major cause of cancer-related deaths among women in the United States and Western Europe (American Cancer Society 1998, Wingo et al. 1998). Most women succumb to breast cancer if their tumors metastasize but cures are more likely if the cancers remain localized (Harris et al. 1992a,b,c, Walker et al. 1997). Thus, a greater understanding of the metastatic process in human breast cancer should translate into substantial improvements in therapeutic outcome for breast cancer patients. Towards that end, we will review and summarize the literature about, and begin to develop a working model for, the genetics of human breast cancer metastasis. There have been great strides in recent years with regard to our overall understanding of metastasis. Yet our apparently straightforward objective - to define cause-effect relationships for genes in breast cancer - was difficult because of four issues. First, many reports fail to distinguish between oncogenesis and progression or invasion and metastasis when reporting data. Secondly, there is a failure, by some, to recognize that breast cancer is not a single disease, but a collection of diseases. This is particularly apparent in the genetics literature. Thirdly, it is difficult to evaluate the relative importance of correlative data, particularly as it relates to mechanistic control of steps in the metastatic cascade. Fourthly, there is a tremendous noise-to-signal ratio for genetics of late-stage, metastatic breast cancers resulting from genotypic instability, phenotypic drift and tumor heterogeneity.

Note:

Acknowledgements

We are particularly indebted to Dr Bernard E Weissman from the University of North Carolina at Chapel Hill. Much of the published work described here was done in conjunction with his laboratory. We also appreciate the efforts of Andrea Manni, P G Satyaswaroop, Michael Verderame, and Steven Goldberg for critical reading and helpful comments and suggestions. We also appreciate the support of grants from the US Army Medical Research and Material Command (DAMD17-96-6152 to D R W); the National Foundation for Cancer Research (to D R W and L L W); PHS grant CA62168 (to D R W), the Latham Fund (L L W) and the Jake Gittlen Memorial Golf Tournament (D R W).

This article has been cited by other articles:

				W. J. Meehan, R. S. Samant, J. E. Hopper, M. J. Carrozza, L. A. Shevde, J. L. Workman, K. A. Eckert, M. F. Verderame, and D. R. Welch Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription J. Biol. Chem., January 9, 2004; 279(2): 1562 - 1569. [Abstract] [Full Text] [PDF]

				S. F. Goldberg, M. E. Miele, N. Hatta, M. Takata, C. Paquette-Straub, L. P. Freedman, and D. R. Welch Melanoma Metastasis Suppression by Chromosome 6: Evidence for a Pathway Regulated by CRSP3 and TXNIP Cancer Res., January 15, 2003; 63(2): 432 - 440. [Abstract] [Full Text] [PDF]

				K. W. Hunter, K. W. Broman, T. L. Voyer, L. Lukes, D. Cozma, M. T. Debies, J. Rouse, and D. R. Welch Predisposition to Efficient Mammary Tumor Metastatic Progression Is Linked to the Breast Cancer Metastasis Suppressor Gene Brms1 Cancer Res., December 1, 2001; 61(24): 8866 - 8872. [Abstract] [Full Text] [PDF]

				M. J. Seraj, R. S. Samant, M. F. Verderame, and D. R. Welch Functional Evidence for a Novel Human Breast Carcinoma Metastasis Suppressor, BRMS1, Encoded at Chromosome 11q13 Cancer Res., June 1, 2000; 60(11): 2764 - 2769. [Abstract] [Full Text] [PDF]

				D. R. Welch, T. Sakamaki, R. Pioquinto, T. O. Leonard, S. F. Goldberg, Q. Hon, R. L. Erikson, M. Rieber, M. S. Rieber, D. J. Hicks, et al. Transfection of Constitutively Active Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase Confers Tumorigenic and Metastatic Potentials to NIH3T3 Cells Cancer Res., March 1, 2000; 60(6): 1552 - 1556. [Abstract] [Full Text]

				M. Nacht, A. T. Ferguson, W. Zhang, J. M. Petroziello, B. P. Cook, Y. H. Gao, S. Maguire, D. Riley, G. Coppola, G. M. Landes, et al. Combining Serial Analysis of Gene Expression and Array Technologies to Identify Genes Differentially Expressed in Breast Cancer Cancer Res., November 1, 1999; 59(21): 5464 - 5470. [Abstract] [Full Text] [PDF]

				D. R. Welch and C. W. Rinker-Schaeffer What Defines a Useful Marker of Metastasis in Human Cancer? J Natl Cancer Inst, August 18, 1999; 91(16): 1351 - 1353. [Full Text] [PDF]

				A. T. Ferguson, E. Evron, C. B. Umbricht, T. K. Pandita, T. A. Chan, H. Hermeking, J. R. Marks, A. R. Lambers, P. A. Futreal, M. R. Stampfer, et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer PNAS, May 23, 2000; 97(11): 6049 - 6054. [Abstract] [Full Text] [PDF]